113 related articles for article (PubMed ID: 33482186)
1. Knocking down of Polo-like kinase 2 inhibits cell proliferation and induced cell apoptosis in human glioma cells.
Cao F; Xia X; Fan Y; Liu Q; Song J; Zhang Q; Guo Y; Yao S
Life Sci; 2021 Apr; 270():119084. PubMed ID: 33482186
[TBL] [Abstract][Full Text] [Related]
2. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer.
Ou B; Zhao J; Guan S; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Zheng M; Feng H; Lu A
Cancer Lett; 2016 Oct; 380(2):457-466. PubMed ID: 27423313
[TBL] [Abstract][Full Text] [Related]
3. Silencing of polo-like kinase 2 increases cell proliferation and decreases apoptosis in SGC-7901 gastric cancer cells.
Liu LY; Wang W; Zhao LY; Guo B; Yang J; Zhao XG; Song TS; Huang C; Xu JR
Mol Med Rep; 2015 Apr; 11(4):3033-8. PubMed ID: 25501818
[TBL] [Abstract][Full Text] [Related]
4. Polo-Like Kinase 2 is Dynamically Regulated to Coordinate Proliferation and Early Lineage Specification Downstream of Yes-Associated Protein 1 in Cardiac Progenitor Cells.
Mochizuki M; Lorenz V; Ivanek R; Della Verde G; Gaudiello E; Marsano A; Pfister O; Kuster GM
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066438
[TBL] [Abstract][Full Text] [Related]
5. Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer.
Han T; Lin J; Wang Y; Fan Q; Sun H; Tao Y; Sun C
Biomed Pharmacother; 2018 Jul; 103():1369-1375. PubMed ID: 29864920
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of PLK1 inhibits invasion and promotes apoptosis in glioma cells through regulating autophagy.
Wu ZY; Wei N
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2723-2733. PubMed ID: 29771424
[TBL] [Abstract][Full Text] [Related]
8. CHOP negatively regulates Polo-like kinase 2 expression via recruiting C/EBPα to the upstream-promoter in human osteosarcoma cell line during ER stress.
Shen T; Li Y; Chen Z; Liang S; Guo Z; Wang P; Wu Q; Ba G; Fu Q
Int J Biochem Cell Biol; 2017 Aug; 89():207-215. PubMed ID: 28652211
[TBL] [Abstract][Full Text] [Related]
9. RING finger gene 180 inhibits osteosarcoma progression through regulating chromobox homolog 4 ubiquitination.
Zhao Q; Liu N; Xu T; Song K
Cell Cycle; 2023 May; 22(10):1246-1258. PubMed ID: 37095741
[TBL] [Abstract][Full Text] [Related]
10. E3 ubiquitin ligase RNF180 impairs IPO4/SOX2 complex stability and inhibits SOX2-mediated malignancy in ovarian cancer.
Zhao H; Bi F; Li M; Diao Y; Zhang C
Cell Signal; 2024 Jan; 113():110961. PubMed ID: 37923100
[TBL] [Abstract][Full Text] [Related]
11. RNF180 mediates STAT3 activity by regulating the expression of RhoC via the proteasomal pathway in gastric cancer cells.
Wu Z; Liu H; Sun W; Du Y; He W; Guo S; Chen L; Zhao Z; Wang P; Liang H; Deng J
Cell Death Dis; 2020 Oct; 11(10):881. PubMed ID: 33082325
[TBL] [Abstract][Full Text] [Related]
12. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.
Zhang T; Ji D; Wang P; Liang D; Jin L; Shi H; Liu X; Meng Q; Yu R; Gao S
Cancer Lett; 2018 Feb; 415():151-163. PubMed ID: 29233656
[TBL] [Abstract][Full Text] [Related]
13. Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.
Fingas CD; Mertens JC; Razumilava N; Sydor S; Bronk SF; Christensen JD; Rizvi SH; Canbay A; Treckmann JW; Paul A; Sirica AE; Gores GJ
Hepatology; 2013 Oct; 58(4):1362-74. PubMed ID: 23703673
[TBL] [Abstract][Full Text] [Related]
14. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H
Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870
[TBL] [Abstract][Full Text] [Related]
15. Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib.
Yamashita Y; Morita S; Hosoi H; Kobata H; Kishimoto S; Ishibashi T; Mishima H; Kinoshita A; Backes BJ; Yoshiura KI; Papa FR; Sonoki T; Tamura S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878237
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer.
Yuan Y; Chen X; Huang E
Technol Cancer Res Treat; 2019; 18():1533033819886867. PubMed ID: 31694481
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
Guo SK; Shen MF; Yao HW; Liu YS
Cell Physiol Biochem; 2018; 49(3):1097-1109. PubMed ID: 30196284
[TBL] [Abstract][Full Text] [Related]
18. UHRF2 mRNA expression is low in malignant glioma but silencing inhibits the growth of U251 glioma cells in vitro.
Wu TF; Zhang W; Su ZP; Chen SS; Chen GL; Wei YX; Sun T; Xie XS; Li B; Zhou YX; Du ZW
Asian Pac J Cancer Prev; 2012; 13(10):5137-42. PubMed ID: 23244124
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop.
Valenti F; Fausti F; Biagioni F; Shay T; Fontemaggi G; Domany E; Yaffe MB; Strano S; Blandino G; Di Agostino S
Cell Cycle; 2011 Dec; 10(24):4330-40. PubMed ID: 22134238
[TBL] [Abstract][Full Text] [Related]
20. BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.
Wang B; Cao C; Liu X; He X; Zhuang H; Wang D; Chen B
Cell Oncol (Dordr); 2020 Apr; 43(2):223-235. PubMed ID: 31776938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
